Neos Therapeutics (NEOS) Tops Q2 EPS by 2c

Neos Therapeutics (NASDAQ: NEOS) reported Q2 EPS of ($0.11), $0.02 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $13.1 million versus the consensus estimate of $12.17 million.

For earnings history and earnings-related data on Neos Therapeutics (NEOS) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c